Hue Test Research Articles

Lanthony 15-Hue Desaturated Test for Screening of Early Color Vision Defects in Uncomplicated Juvenile Diabetes

Purpose: To identify the most appropriate test for screening of early color vision abnormalities in uncomplicated juvenile diabetes. Methods: Enrolled in this study were 39 diabetic adolescents, characterized by optimal Early Treatment Diabetic Retinopathy Study criteria for visual acuity, transparent dioptric means and angiographically normal retinas. Color vision was examined with Standard Pseudoisochromatic Plates (Part 2, SPP2), Roth 28-Hue Test (R28), Farnsworth-Munsell 100-Hue Tests (FM100), and Lanthony 15-Hue Desaturated Test (L15). Color confusion score (CCS) and desaturation angle (DSAT) were measured on L15 only. Thirty-nine normal subjects served as a control group. Poor metabolic control was an exclusion criteria. Results: CCS was significantly higher in the patients than in the controls (37.8 ± 11.1 vs 0 ± P < .001) and normal scores were found in only 4 diabetic patients. DSAT values were spread, not showing a well-defined axis of the defect. The results of FM100 were clinically reliable but affected by a longer execution time. R28 and SPP2 demonstrated a low sensitivity, as all patients scored normally with both tests. Conclusions: Impaired color vision is a common observation even in patients with uncomplicated juvenile diabetes. Our results indicate that L15 is the most suitable test for screening of early color vision abnormalities in these subjects.

Influence of the luminance level on visual performance with a disposable soft cosmetic tinted contact lens

The purpose of the present work was to study the effect on visual performance of wearing disposable soft tinted contact lenses for cosmetic purposes. Parameters such as contrast sensitivity (Vistech 6000), colour vision (Farnsworth-Munsell 100-Hue colour test), visual fields (static Goldmann perimetry) and subjective vision (what the wearer feels while wearing the lenses) were studied under different illumination levels in order to check for possible vision losses while wearing these contact lenses at low illumination levels. Sixteen emmetropic subjects were fitted consecutively with seven pairs of different colour lenses (Optima Colors® lenses by Bausch & Lomb), and the experimental parameters were measured under four different illumination levels (60, 6, 1, and 0.1cd/m2; but 15 and 0.3cd/m2 for the static perimetry) The results obtained showed no statistically significant differences in visual performance between wearing the lenses and not wearing them (p>0.01), except for the static perimetry, in which statistically significant differences (p<0.01) occur at eccentricities greater than 30°.

Color vision testing in an area with high levels of ambient illumination

This study evaluated the color discrimination of adults who were exposed to long durations of sunlight during their lifetime. The Farnsworth-Munsell 100-Hue test was used to examine the color vision of 141 subjects (mean age, 46.5 years), who had no ocular diseases and whose visual acuities ranged from 20/40 to 20/16. Results showed higher total error scores than previously published norms. There was a tendency for blue-yellow axis, especially in men older than 45 years. Long exposures of ambient light may cause color vision deficiencies.

Color vision after laser in situ keratomileusis

Purpose To evaluate the effect of laser in situ keratomileusis (LASIK) on color vision. Setting Department of Ophthalmology, China Medical College Hospital, Taichung, Taiwan. Method This prospective study comprised consecutive patients having LASIK. Patients were eligible for inclusion if they had a best corrected visual acuity of 20/20 or better and a normal color vision test preoperatively and an uncorrected near visual acuity of 20/40 or better postoperatively. Color vision was tested using the Farnsworth-Munsell 100-hue test (FM 100 test) preoperatively and 1 day, 1 week, and 1 month postoperatively. Results Twenty-nine eyes of 15 patients having LASIK were enrolled in the study. The mean patient age was 29.2 years ± 2.9 (SD). The mean preoperative spherical equivalent refractive error was −5.6 ± 1.8 diopters, and the mean preoperative error score of the FM 100 test was 3.79 ± 1.55. After surgery, no significant change in the error score was observed at 1 day (4.30 ± 1.07, P = .1039, paired t test), 1 week (3.72 ± 1.25, P = .8125, paired t test), or 1 month (3.97 ± 1.29, P = .6149, paired t test). Conclusion Laser in situ keratomileusis did not affect color vision evaluated by the FM 100 test.

Color vision deficiencies in Gilles de la Tourette syndrome

Color perception was tested using the Farnsworth–Munsell 100-Hue Test in a sample of persons with Gilles de la Tourette syndrome (GTS), and compared to norms from three age cohorts in the early second, fourth and sixth decades. Red-green color errors on the Farnsworth–Munsell did not appear to change appreciably as a function of age or GTS. Blue-yellow error scores did, however, increase with age and were exaggerated in the GTS group. It is concluded that sensory and perceptual disturbances are present in GTS as in other basal cell ganglia disorders. The results are discussed in terms of converging retinal dopaminergic mechanisms also associated with Parkinson's and Huntington's diseases and even with normal aging. Suggestions are offered that daily activities and behavior may be affected by spatial and chromatic deficiencies.

Normal test scores in the Farnsworth-Munsell 100 hue test.

One hundred and sixty persons aged from 10 to 69 years (106 women, 54 men) with healthy eyes were studied with the Farnsworth-Munsell 100 hue (FM100) test. The mean of the results in the total scores and in the individual box scores in the right and left eye were calculated. The total score was also separately calculated in women and men. The test was administered under the illumination of Macbeth Easel lamp, 1000 lux, and the right eye was tested first. The results were calculated in six different age groups, 10-19 years, 20-29 years, etc. The mean of the total scores in the right eye varied from 7.44+/-2.46 (SD) to 10.07+/-2.03 in different age groups and in the left eye from 7.56+/-2.36 to 10.16+/-2.68. The scores changed significantly with the age: the correlation between the age and the test scores by linear regression gave significant results, in the right eye (R = 0.308, P = 0.0001), and in the left eye (R = 0.246, P = 0.0021). The present study with the normal error scores in the FM100 test and its individual boxes in persons aged 10-69 years gives clinicians working with colour vision defects a possibility to estimate the normality or abnormality of the results in their patients.

Colour-vision tests considered as a special case of multidimensional scaling

Panel tests of colour vision such as the D15 and Farnsworth–Munsell 100-Hue tests are designed to classify people into broad categories of normal or deficient colour vision. Our interest lies in finer measurements within these categories. We apply the insights and methods of multidimensional scaling to individuals' performances on the D15 and 100-Hue tests, by interpreting these as information about the similarities between pairs of the test stimuli (16 and 85 stimuli, respectively). The results are quantitative descriptions of individual performances on the tests. There are implications for more objective test interpretations and diagnosis of colour-vision deficiencies. © 2000 John Wiley & Sons, Inc. Col Res Appl, 25, 160–169, 2000

Validação clínica de teste psicofísico computadorizado para avaliação de visão de cores e sensibilidade ao contraste

Purpose: To determine the reliability of TwoDocs compu-terized test for the evaluation of color vision and contrast sensitivity in normal adults. Methods: Thirty normal volunteers aged from 20 to 30 years (mean 23.3 years) had their color vision and contrast sensitivity tested by a new computerized test (TwoDocs test). Informed consent was obtained from all participants before testing. Inclusion criteria were: absence of visual com-plaints, absence of previous ophthalmic surgery, absence of family history of ophthalmologic diseases, best corrected visual acuity for near and distance of 20/20. Tests with the Farnsworth-Munsell 100-hue (FM-100) test for color vision assessment and the Pelli-Robson chart for contrast sensitivity measurement were also performed on the same visit, and both were considered gold standards for clinical validation. Results: The results of contrast sensitivity obtained with the Pelli-Robson chart and TwoDocs test showed agreement of 100%. Color vision results obtained with the TwoDocs test showed a strong trend to overestimate color vision classification when compared with FM-100. Conclusion: The new computerized psychophysical TwoDocs test showed a high sensitivity and specificity for contrast sensitivity measurement and can be a useful clinical tool in ophthalmology practice for this visual task. Color vision classification obtained with the TwoDocs test showed a low specificity when compared with FM-100. One possible reason for this overestimation is the computer monitor used to generate the color pattern. Additional studies in patients with disorders in color vision should be done for understan-ding the usefulness of this method better in clinical color vision assessment.

A functional MRI case study of acquired cerebral dyschromatopsia

Evidence from imaging studies suggests that primary visual cortex and multiple areas in ventral occipitotemporal cortex subserve color perception in humans. To learn more about the organization of these areas, we used structural and functional MRI (fMRI) to examine a patient with damage to ventral cortex. An art professor, KG, suffered a cerebrovascular accident during heart surgery that impaired his ability to perceive color. The Farnsworth–Munsell 100-Hue test was used to assess the extent of his deficit. When tested 12 months after the lesion, KG performed worse than 95% of age-matched normals on the 100-Hue test, but well above chance. Structural and functional MRI studies were conducted 3 years after the lesion to investigate the neuroanatomical correlates of KG’ss remaining color ability. Structural MRI revealed bilateral damage to ventral occipitotemporal cortex. In young and age-matched normal controls, an fMRI version of the 100-Hue reliably activated bilateral, color-selective regions in primary visual cortex and anterior and posterior ventral cortex. In subject KG, color-selective cortex was found in bilateral primary visual cortex. In ventral cortex, no color-selective activity was observed in right ventral cortex, and only a small area of activity was observed in left anterior ventral cortex. However, significant color-selective activity was observed in posterior left ventral cortex spared by the lesion. This posterior left ventral activation was similar in extent, position, and degree of color-selectivity to the posterior left posterior activation observed in normal controls, suggesting that this focus may be the cortical substrate underlying KG’s remaining color perception.

Color vision in epilepsy patients treated with vigabatrin or carbamazepine monotherapy

Purpose To investigate color vision in epilepsy patients treated with vigabatrin or carbamazepine monotherapy and to evaluate the association between vigabatrin-induced visual field defects and dyschromatopsia. Design Nonrandomized comparative trial. Participants Thirty-two epilepsy patients treated with vigabatrin monotherapy, 18 patients treated with carbamazepine monotherapy, and 47 age-matched healthy controls were examined. Main outcome measures Color vision was examined with Standard Pseudoisochromatic Plates 2 (SPP2) screening test, Farnsworth-Munsell 100 (FM 100) hue test, and Color Vision Meter 712 anomaloscope. Results Abnormal color perception was found in 32% of the epilepsy patients treated with vigabatrin monotherapy and 28% of the epilepsy patients treated with carbamazepine monotherapy. The total error score in the Farnsworth-Munsell 100 hue test was abnormally high in the vigabatrin monotherapy patients who had concentrically constricted visual fields and a statistically significant correlation was found between the temporal visual field extents and the age-adjusted Farnsworth-Munsell 100 total error score in vigabatrin monotherapy patients ( R = .533, P = 0.003 in the right eye, R = .563, P = 0.001 in the left eye). Four of 31 (12%) vigabatrin monotherapy patients, and 1 of 18 (6%) carbamazepine monotherapy patients had a blue axis in Farnsworth-Munsell 100 hue test. In the anomaloscope, there were a few pathologic findings in both groups. In the SPP2 screening test, a few plates were not seen in both groups. Conclusions Both examined antiepileptic drugs, vigabatrin and carbamazepine, cause acquired color vision defects. The abnormal color perception seems to be associated with constricted visual fields in the vigabatrin monotherapy patients. The duration of carbamazepine therapy correlates with high FM100 total error score. The best method for detecting dyschromatopsia in patients treated with vigabatrin or carbamazepine was the Farnsworth-Munsell 100 hue test. The SPP2 screening test does not seem to be useful in clinical practice.

加齢による水晶体黄変が色覚におよぼす効果

We conducted four kinds of psychophysical measurements on color vision to investigate whether the change in lens spectral transmittance that comes with aging is the primary factor in the change in color vision. We asked two observers (22 and 24 years old) to adapt to the scene while wearing goggles equipped with filters that simulate spectral transmittance at the retinal level of a person of 80 years old, when worn by 20 years old observer. During the test, which lasted as long as 12 hours, the observers performed (1) unique-white setting, (2) heterochromatic flicker photometry (HFP), (3) heterochromatic brightness matching (HBM), and (4) 100-hue test. The change in the results with and without the goggle showed that only difference in HFP sensitivity coincided exactly with the filter transmittance. A similar tendency was found in the difference between 20 and 80year-old observers in a previous study. The other tests matched with neither the difference in spectral transmittance nor the difference between 20-and 80year-old experimental results. Our results suggest that neural circuits, which may differ from those for illuminant change, play a significant role in correcting the relative spectrum change on the retina.

Color vision defects after central serous chorioretinopathy.

To reexamine patients diagnosed with central serous chorioretinopathy (CSC) during the 10-year period from 1987 to 1996 to identify remaining color vision defects in the eyes with normal visual acuity (VA). Thirty-nine patients were found with normal VA of 20/20 (logMAR 0) or better 8 to 166 months (mean +/- SD, 58.8 +/- 41.2) after active CSC. Color vision was examined with the Standard Pseudoisochromatic Plates part 2, Farnsworth-Munsell 100 hue test, and Color Vision Meter 712 anomaloscope. Of the CSC eyes, 26 (67%) had a color vision defect, most of them in the blue area. There was no correlation between the time since the active disease and the results on the color vision tests. Of the contralateral eyes, 19 (49%) also had a color vision defect. In many patients some degree of color vision defect remains after CSC even if the VA has recovered to normal. The contralateral eye can also have a color vision defect. This has not been previously reported and might be due to earlier subclinical CSC.

Visual acuity and color vision deficiency in amblyopia.

To investigate color vision and its relation with the type of amblyopia and visual acuity of amblyopic eyes. In this prospective study, 67 amblyopic eyes of 64 patients, aged from 4 to 13 years (mean 6.8 +/- 2.1) and 26 eyes of 13 control subjects aged from 5 to 13 years (mean 7.3 +/- 1.6) were examined with the Farnsworth-Munsell 100 Hue Test (FM-100). Amblyopic eyes were grouped as strabismic (21 eyes) and anisometropic (46 eyes). Each group was subdivided according to their visual acuity, as less than 5/10 and 6/10 or better. The total errors, blue-yellow (B-Y) and red-green (R-G) partial error scores were obtained for each group. One-way ANOVA was used to assess differences between groups. The error scores of all axes were lower in the control group than the amblyopic groups (p<0.001), but the differences within amblyopic groups were not significant (p>0.05). Deficient color vision in the amblyopic eyes was not related to the visual acuity and type of amblyopia.

Decreased color discrimination and contrast sensitivity in Parkinson's disease.

Patients with Parkinson's disease (PD) often complain of blurred vision or even of distinctive visual disturbances like hallucinations and illusions. Recent studies have emphasized the potential influence of primary visual deficits of color and contrast discrimination. To study primary visual function, we studied color discrimination (CD) and contrast sensitivity (CS) during 'on' medication in PD patients and compared them to non-PD subjects. Twenty one PD patients were compared to 30 age-matched controls using CD tested by the D-15 Lanthony test (D15) and the Farnsworth-Munsell 100 Hue test (FM) and CS tested by the Pelli-Robson (PL) and the Vis-Tech tables (VT). We excluded subjects with a visual acuity </=0.6 Snellen fraction or known ophthalmological diseases. PD patients showed greater impairment on all visual tests than controls. This difference was significant for the FM test (P<0.001), the spatial frequencies 12 and 18 cpd (cycles per degree) of the VT test (P<0.05) and both the monocular and binocular PR tests (P<0.05). Most tests for CS and CD showed statistical independency. CS deficits, but not CD deficits, correlated with age in both patients and controls. This study documents major and independent impairment of both color and contrast discrimination in PD patients. Further studies should elucidate possible clinical implications and correlations, such as the frequency of falls or visual hallucinations.

Colour vision abnormalities and movement time in Parkinson's disease.

Visual system dysfunction has been reported in Parkinson's disease (PD). The objective of the present study was to evaluate a putative association of distorted colour vision and delayed initiation and execution of movement in PD. We performed the Farnsworth-Munsell 100-hue test and estimated the total error score in 30 previously untreated parkinsonian patients and 30 age- and sex-matched controls. We then determined slowness in motor readiness and motor programming in the parkinsonian subjects on the same day. Subjects were asked to press a start button and release it after the randomized appearance of a visual stimulus and to move their right index finger to a reaction button as quickly as possible. Reaction time was considered as elapsed time between onset of the stimulus light and release of the start button, movement time was the time period between release of the start button and the pressing of the reaction button. Significant differences appeared between parkinsonian patients' and controls' reaction times (P = 0.007), movement time (P = 0.001) and total error score (P = 2.23E-08). A significant relation (Spearman R = 0.473, P = 0.008) was found between movement time and total error score, but not between reaction time and total error score (Spearman R = 0.259, P = 0.166). We conclude, that visual dysfunction and execution of movement are more influenced by altered dopaminergic neurotransmission in PD in comparison to the initiation of movement.

Impaired color vision associated with diabetic retinopathy: Early Treatment Diabetic Retinopathy Study Report No. 15

PURPOSE: To report color vision abnormalities associated with diabetic retinopathy. METHODS: Color vision function was measured at baseline in 2,701 patients enrolled in the Early Treatment Diabetic Retinopathy Study, a randomized trial investigating photocoagulation and aspirin in the treatment of diabetic retinopathy. Hue discrimination was measured by the Farnsworth-Munsell 100-Hue test, and errors in color vision were reported as the square root of the total 100-Hue (SQRT 100-Hue) score. RESULTS: Approximately 50% of the Early Treatment Diabetic Retinopathy Study population had color vision scores (SQRT 100-Hue score) worse than 95% of the normal population reported by Verriest and associates. The factors most strongly associated with impaired hue discrimination were macular edema severity, age, and presence of new vessels. A tritan-like defect was prominent and increased in magnitude with increasing severity of macular edema. However, many patients had color discrimination impairment without macular edema. CONCLUSIONS: Impaired color vision is a common observation among participants enrolled in the Early Treatment Diabetic Retinopathy Study. Compared with published data on normal subjects, approximately 50% of the patients in the Early Treatment Diabetic Retinopathy Study had abnormal hue discrimination. Macular edema severity, age, and the presence of new vessels were the factors most strongly associated with impaired color discrimination. A tritan-like defect was prominent and increased in magnitude with increasing severity of macular edema. Impaired color vision should be considered in the evaluation and counseling of patients with diabetic retinopathy.

Diabetic versus non-diabetic colour vision after cataract surgery

AIMSTo examine whether the colour vision abnormalities found in phakic patients with diabetes mellitus is preserved after removal of the lens by cataract surgery.METHODS21 diabetic (16 IDDM and five NIDDM)...

Effect of the tuberculostaticum ethambutol and stimulus intensity on chromatic discrimination in man

In goldfish it has been shown that ethambutol shifts the threshold for wavelength discrimination without affecting the absolute sensitivity of the cones. In this study we demonstrate that a similar colour vision disturbance occurs in tuberculosis patients treated with ethambutol. After 2 months of ethambutol treatment, chromatic discrimination was measured with a computerized forced two choice (CD) test with isoluminant coloured stimuli and with three other colour vision tests: the Ishihara, the Oscar and the Lanthony Desaturated 15 Hue tests. The scores of the patient group ( n=19) on these four colour vision tests were compared with the scores of a group of control subjects ( n=33) and a group of congenital red/green colour-blind subjects ( n=5). A reduction of the stimulus intensity of 1 log unit caused a significant reduction in red/green chromatic discrimination, measured with the CD test in both, control subjects and patients. This intensity dependent reduction was significantly greater for patients than for controls. In this respect, man and goldfish behave similarly. Furthermore, the CD test showed the same ethambutol-induced reduction in chromatic discrimination at low intensity for the blue/green part of the spectrum. This has not been measured in goldfish. The origin of this ethambutol-induced colour vision disturbance must be at a post-photoreceptor site, because the Ishihara and Oscar tests, both designed to screen for photoreceptor-based, or primary red/green colour vision disturbances, did not discriminate between patients and control subjects. Thus, as in goldfish, we find that in patients ethambutol shifts the threshold for chromatic discrimination without changing the absolute sensitivity.

Assessment of Colour Vision in Epileptic Patients Exposed to Single-Drug Therapy

Diplopia, blurred vision and colour disturbances are well-known side effects associated with anti-epileptic drugs (AEDs). Farnsworth-Munsell 100-hue colour test (F-100) is an accepted and sensitive tool to detect changes in colour perception. To determine the impact of AEDs upon colour vision, we evaluated 37 consecutive patients with complex partial seizures exposed to monotherapy with phenytoin (PHT, carbamazepine (CBZ) or valproic acid (VPA). All had normal IQ and no congenital disturbances in colour vision or ocular diseases. Twenty normal controls were used for statistical analysis. Thirteen patients were exposed to PHT, 12 to CBZ and 12 to VPA. Visual colour perception was impaired in 30/37 (82%) of the study group. The most significant abnormality was detected in the blue-yellow axis in 10/13 patients exposed to PHT (p < 0.02) and in 8/12 treated with CBZ (p < 0.009). In 8/12 patients taking VPA, no significant abnormality was observed (p < 0.06). None of the studied patients complained of colour vision disturbances. Our findings strongly support the negative effect of AEDs upon colour vision discrimination, most likely due to changes at the retinal processing level. F-100 proved to be very useful to assess early toxicity due to AEDs.

Development of brightness matching and colour vision deficits in juvenile diabetics

We studied hue discrimination and brightness matching throughout the spectrum in ten juvenile patients suffering from diabetes mellitus (Type I) with no (eight patients) or mild (two patients) retinopathy. In addition, the FM 100-Hue test was performed. The data were collected once every year over 5 years. Over the 5 years, the diabetics show a continual change in the shape of their brightness matching function. Wavelength discrimination ability remains quite stable with time at the long end of the spectrum but is variable at short wavelengths. FM-100 error scores remain similar over the period tested, at a level slightly higher than that of a control group. Additional experiments show that the sensitivity of the S-cone in the diabetic group is similar to that of controls. The results can be explained by an early relative reduction in the sensitivity of post-receptoral processes in juvenile diabetics.